The results showed that semaglutide improved both short-term and long-term memory in the Alzheimer’s model mice. In a test ...

Half of the participants took a semaglutide tablet daily and half took a placebo. Participants continued their assigned regimen for an average of just under four years. By the end of the trial ...

CHICAGO -- Semaglutide further solidified its efficacy ... Participants were told to take their assigned tablet in the morning, with a little water and no food or other medications until at ...

Semaglutide 2.4 mg reduced total cardiovascular events by 22% in people with established cardiovascular disease (CVD) and overweight or obesity without diabetes. 1 Obesity directly leads to ...

The use of semaglutide in patients with diabetes was associated with a significantly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) compared with those taking drugs for ...

66), suggesting an independent treatment benefit with oral semaglutide, McGuire said. “Delivery of this tablet is more complicated than usual,” McGuire told Healio. “Because of the mechanism ...

The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ...